Company / Financials
OptimizeRx Corp Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$92.1M
FY2025 · +28.8% YoY
Net Income
-$20.1M
FY2025 · -14.5% YoY
Profit Margin
-21.8%
FY2025 · net income / revenue
ROE
-17.2%
FY2025 · return on equity
Total Assets
$176.9M
FY2025
Total Debt
$26.3M
0.22x debt/equity
Equity
$117.0M
FY2025
ROA
-11.4%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$92.1M+28.8% YoYNet Income HistoryProfit after all expenses and taxes-$20.1M-14.5% YoYGross Profit HistoryRevenue minus cost of goods sold$59.4M+38.4% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$32.7M+14.4% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$13.7M+48.1% YoYSG&A Expense HistorySelling, general, and administrative expenses$27.7MR&D Expense HistoryResearch and development spending$0Interest Expense HistoryCost of borrowing and debt obligations$1.5MIncome Tax HistoryTotal income tax expense$725.0K+109.5% YoYEPS (Basic) HistoryBasic earnings per share-$1.10-6.8% YoY